AAAAAA
Results: 26-40/40
Authors:
VANLEEUWEN FE
Citation: Fe. Vanleeuwen, BREAST-CANCER RISK AFTER INDUCED-ABORTION, A DUTCH CASE-CONTROL STUDY, American journal of epidemiology, 141(11), 1995, pp. 54-54
Authors:
TRAVIS LB
CURTIS RE
STOVALL M
HOLOWATY EJ
VANLEEUWEN FE
GLIMELIUS B
LYNCH CF
HAGENBEEK A
LI CY
BANKS PM
GOSPODAROWICZ MK
ADAMI J
WACHOLDER S
INSKIP PD
TUCKER M
BOICE JD
Citation: Lb. Travis et al., RISK OF LEUKEMIA FOLLOWING TREATMENT FOR NON-HODGKINS-LYMPHOMA, Journal of the National Cancer Institute, 86(19), 1994, pp. 1450-1457
Authors:
VANLEEUWEN FE
CHORUS AMJ
VANDENBELTDUSEBOUT AW
HAGENBEEK A
NOYON R
VANKERKHOFF EHM
PINEDO HM
SOMERS R
Citation: Fe. Vanleeuwen et al., LEUKEMIA RISK FOLLOWING HODGKINS-DISEASE - RELATION TO CUMULATIVE DOSE OF ALKYLATING-AGENTS, TREATMENT WITH TENIPOSIDE COMBINATIONS, NUMBEROF EPISODES OF CHEMOTHERAPY, AND BONE-MARROW DAMAGE, Journal of clinical oncology, 12(5), 1994, pp. 1063-1073
Authors:
VANLEEUWEN FE
KLOKMAN WJ
HAGENBEEK A
NOYON R
VANDENBELTDUSEBOUT AW
VANKERKHOFF EHM
VANHEERDE P
SOMERS R
Citation: Fe. Vanleeuwen et al., 2ND CANCER RISK FOLLOWING HODGKINS-DISEASE - A 20-YEAR FOLLOW-UP-STUDY, Journal of clinical oncology, 12(2), 1994, pp. 312-325
Authors:
ROOKUS MA
VANLEEUWEN FE
Citation: Ma. Rookus et Fe. Vanleeuwen, ORAL-CONTRACEPTIVES AND RISK OF BREAST-CANCER IN WOMEN AGED 20-54 YEARS, Lancet, 344(8926), 1994, pp. 844-851
Authors:
VANLEEUWEN FE
Citation: Fe. Vanleeuwen, ENDOMETRIAL CANCER DURING TAMOXIFEN TREATMENT (VOL 343, PG 978, 1994), Lancet, 343(8904), 1994, pp. 1048-1048
Authors:
VANLEEUWEN FE
Citation: Fe. Vanleeuwen, ENDOMETRIOSIS DURING TAMOXIFEN TREATMENT - REPLY, Lancet, 343(8903), 1994, pp. 978-978
Authors:
VANLEEUWEN FE
BENRAADT J
COEBERGH JWW
KIEMENEY LALM
GIMBRERE CHF
OTTER R
SCHOUTEN LJ
DAMHUIS RAM
BONTENBAL M
DIEPENHORST FW
VANDENBELTDUSEBOUT AW
VANTINTEREN H
Citation: Fe. Vanleeuwen et al., RISK OF ENDOMETRIAL CANCER AFTER TAMOXIFEN TREATMENT OF BREAST-CANCER, Lancet, 343(8895), 1994, pp. 448-452
Authors:
VANLEEUWEN FE
NOYON R
Citation: Fe. Vanleeuwen et R. Noyon, RISK-FACTORS FOR 2ND CANCER AFTER BREAST-CANCER, American journal of epidemiology, 139(11), 1994, pp. 190000027-190000027
Authors:
TRAVIS LB
CURTIS RE
GLIMELIUS B
HOLOWATY E
VANLEEUWEN FE
LYNCH CF
ADAMI J
GOSPODAROWICZ M
WACHOLDER S
INSKIP P
TUCKER MA
FRAUMENI JF
BOICE JD
Citation: Lb. Travis et al., 2ND CANCERS AMONG LONG-TERM SURVIVORS OF NON-HODGKINS-LYMPHOMA, Journal of the National Cancer Institute, 85(23), 1993, pp. 1932-1937
Authors:
VASEN HFA
BEEX LVAM
CLETON FJ
COLLETTE HJA
VANDONGEN JA
VANLEEUWEN FE
CROMMELIN MA
KHAN PM
Citation: Hfa. Vasen et al., CLINICAL HETEROGENEITY OF HEREDITARY BREAST-CANCER AND ITS IMPACT ON SCREENING PROTOCOLS - THE DUTCH EXPERIENCE ON 24 FAMILIES UNDER SURVEILLANCE, European journal of cancer, 29A(8), 1993, pp. 1111-1114
Authors:
VANLEEUWEN FE
STIGGELBOUT AM
VANDENBELTDUSEBOUT AW
NOYON R
ELIEL MR
VANKERKHOFF EHM
DELEMARRE JFM
SOMERS R
Citation: Fe. Vanleeuwen et al., 2ND TUMORS AFTER RADIATION TREATMENT OF TESTICULAR GERM-CELL TUMORS -REPLY, Journal of clinical oncology, 11(11), 1993, pp. 2286-2287
Authors:
KRIEK E
VANSCHOOTEN FJ
HILLEBRAND MJX
VANLEEUWEN FE
DENENGELSE L
DELOOFF AJA
DIJKMANS APG
Citation: E. Kriek et al., DNA ADDUCTS AS A MEASURE OF LUNG-CANCER RISK IN HUMANS EXPOSED TO POLYCYCLIC AROMATIC-HYDROCARBONS, Environmental health perspectives, 99, 1993, pp. 71-75
Authors:
ROOKUS MA
BEEMSTERBOER PMM
VANLEEUWEN FE
Citation: Ma. Rookus et al., WHICH FACTORS ARE ASSOCIATED WITH STAGE AT DIAGNOSIS IN BREAST-CANCERPATIENTS, American journal of epidemiology, 138(8), 1993, pp. 600-600
Authors:
VANLEEUWEN FE
BLIEK L
SLUMP E
ROOKUS MA
Citation: Fe. Vanleeuwen et al., USE OF EXOGENOUS PROGESTOGENS IN RELATION TO THE RISK OF BREAST-CANCER, American journal of epidemiology, 138(8), 1993, pp. 611-611